RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. MINTS
M

MINTS portfolio

MINTS has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $99M.
Latest deal: Confo Therapeutics · Aug 5, 2024.
About this page

Its most recent investment on record is Confo Therapeutics's $65M Series B+ round in August 2024, alongside Fund+, Wellington Management, Ackermans & van Haaren and 7 others. That company is in Health and bio. It has co-invested with PMV, V-Bio Ventures and Wellington Management, most often PMV (2 rounds).

What MINTS invests in

How MINTS invests

StageDealsCapital in rounds
Series A 1 50%$34M
Series B+ 1 50%$65M
YearDealsCapital in rounds
2019 1 50%$34M
2024 1 50%$65M

MINTS portfolio companies

CompanyRound with MINTSTotal raisedLatest raise
CConfo Therapeutics
Health and bio
 Series B+ · $65M$99MAug 5, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name MINTS. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists MINTS, which is a subset of its real portfolio. API: /api/v1/investors/mints (get a free API key). More: the most active VC firms and new venture capital funds.